BPIFB1 Is a Lung-Specific Autoantigen Associated with Interstitial Lung Disease

作者：Shum Anthony K; Alimohammadi Mohammad; Tan Catherine L; Cheng Mickie H; Metzger Todd C; Law Christopher S; Lwin Wint; Perheentupa Jaakko; Bour Jordan Helene; Carel Jean Claude; Husebye Eystein S; De Luca Filippo; Janson Christer; Sargur Ravishankar; Dubois Noemie; Kajosaari Merja; Wolters Paul J; Chapman Harold A; Kampe Olle; Anderson Mark S^*

来源：Science Translational Medicine, 2013, 5(206): 206ra139.

DOI：10.1126/scitranslmed.3006998

Interstitial lung disease (ILD) is a complex and heterogeneous disorder that is often associated with autoimmune syndromes. Despite the connection between ILD and autoimmunity, it remains unclear whether ILD can develop from an autoimmune response that specifically targets the lung parenchyma. We examined a severe form of autoimmune disease, autoimmune polyglandular syndrome type 1 (APS1), and established a strong link between an autoimmune response to the lung-specific protein BPIFB1 (bactericidal/permeability-increasing fold-containing B1) and clinical ILD. Screening of a large cohort of APS1 patients revealed autoantibodies to BPIFB1 in 9.6% of APS1 subjects overall and in 100% of APS1 subjects with ILD. Further investigation of ILD outside the APS1 disorder revealed BPIFB1 autoantibodies present in 14.6% of patients with connective tissue disease-associated ILD and in 12.0% of patients with idiopathic ILD. The animal model for APS1, Aire(-/-) mice, harbors autoantibodies to a similar lung antigen (BPIFB9); these autoantibodies are a marker for ILD. We found that a defect in thymic tolerance was responsible for the production of BPIFB9 autoantibodies and the development of ILD. We also found that immunoreactivity targeting BPIFB1 independent of a defect in Aire also led to ILD, consistent with our discovery of BPIFB1 autoantibodies in non-APS1 patients. Overall, our results demonstrate that autoimmunity targeting the lung-specific antigen BPIFB1 may contribute to the pathogenesis of ILD in patients with APS1 and in subsets of patients with non-APS1 ILD, demonstrating the role of lung-specific autoimmunity in the genesis of ILD.

• 出版日期2013-10-9